CERVICAL ADENOCARCINOMA

This study tested a drug called nivolumab in 26 people with cervical cancer that had come back or spread. Nivolumab is an immunotherapy that helps the immune system attack cancer cells. The goal was to see if it could shrink tumors and how safe it was. Results showed some tumor s…

This study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…

This study tests whether adding the drug triapine to standard radiation and chemotherapy (cisplatin) helps women with advanced cervical or vaginal cancer live longer. About 450 women with newly diagnosed, bulky or advanced cancer will be randomly assigned to receive either standa…

This study looks at whether yoga therapy can improve the physical and emotional well-being of people with cervical cancer who are getting chemotherapy and radiation. About 40 patients with stage IB2 to IIIB cervical cancer will take part. The goal is to see if adding yoga to stan…

This study is for people with a certain type of cervical cancer (adenocarcinoma) that has spread locally. Researchers want to see how well the cancer responds to standard radiation and chemotherapy, and then decide if additional surgery, more radiation, or systemic therapy is bes…